Cargando…
Deep Learning Based Drug Screening for Novel Coronavirus 2019-nCov
A novel coronavirus, called 2019-nCoV, was recently found in Wuhan, Hubei Province of China, and now is spreading across China and other parts of the world. Although there are some drugs to treat 2019-nCoV, there is no proper scientific evidence about its activity on the virus. It is of high signifi...
Autores principales: | Zhang, Haiping, Saravanan, Konda Mani, Yang, Yang, Hossain, Md. Tofazzal, Li, Junxin, Ren, Xiaohu, Pan, Yi, Wei, Yanjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266118/ https://www.ncbi.nlm.nih.gov/pubmed/32488835 http://dx.doi.org/10.1007/s12539-020-00376-6 |
Ejemplares similares
-
A novel virtual screening procedure identifies Pralatrexate as inhibitor of SARS-CoV-2 RdRp and it reduces viral replication in vitro
por: Zhang, Haiping, et al.
Publicado: (2020) -
An Integrated Deep Learning and Molecular Dynamics Simulation-Based Screening Pipeline Identifies Inhibitors of a New Cancer Drug Target TIPE2
por: Zhang, Haiping, et al.
Publicado: (2021) -
DeepBindRG: a deep learning based method for estimating effective protein–ligand affinity
por: Zhang, Haiping, et al.
Publicado: (2019) -
DeepBindPoc: a deep learning method to rank ligand binding pockets using molecular vector representation
por: Zhang, Haiping, et al.
Publicado: (2020) -
An Efficient Modern Strategy to Screen Drug Candidates Targeting RdRp of SARS-CoV-2 With Potentially High Selectivity and Specificity
por: Zhang, Haiping, et al.
Publicado: (2022)